Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension, Primary, 4”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableStudy completedNCT00004805
What this trial is testing

Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death

Who this might be right for
Pulmonary HypertensionBronchopulmonary DysplasiaRespiratory Distress Syndrome
National Center for Research Resources (NCRR) 500
Post-approval studies (Phase 4)Study completedNCT02310672
What this trial is testing

REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 89
Post-approval studies (Phase 4)Study completedNCT01305252
What this trial is testing

A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).

Who this might be right for
Hypertension, Pulmonary
Stanford University 21
Post-approval studies (Phase 4)Ended earlyNCT04435782
What this trial is testing

Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 9
Post-approval studies (Phase 4)Study completedNCT03078907
What this trial is testing

Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 108
Post-approval studies (Phase 4)Active Not RecruitingNCT05203510
What this trial is testing

A Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 52
Not applicableStudy completedNCT04472533
What this trial is testing

Serum Bio-markers in Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension, Primary, 4
Papworth Hospital NHS Foundation Trust 377
Post-approval studies (Phase 4)Study completedNCT03344159
What this trial is testing

Spironolactone Therapy in Chronic Stable Right HF Trial

Who this might be right for
Chronic Right-Sided Heart FailurePulmonary Arterial HypertensionPulmonary Hypertension, Primary, 2+3 more
Ottawa Heart Institute Research Corporation 15
Testing effectiveness (Phase 2)UnknownNCT04915300
What this trial is testing

Apabetalone for Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Laval University 72
Post-approval studies (Phase 4)Not Yet RecruitingNCT07600723
What this trial is testing

Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 30
Not applicableStudy completedNCT01468545
What this trial is testing

Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System

Who this might be right for
Pulmonary Arterial Hypertension
Bayer 38
Post-approval studies (Phase 4)Looking for participantsNCT06658522
What this trial is testing

Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)

Who this might be right for
Pulmonary Arterial Hypertension PAHPulmonary Arterial Hypertension WHO Group IPulmonary Arterial Hypertension
Amsterdam UMC, location VUmc 20
Very early researchStudy completedNCT03655704
What this trial is testing

Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study

Who this might be right for
Pulmonary Arterial Hypertension
Steeve Provencher 7
Not applicableStudy completedNCT00250640
What this trial is testing

Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years

Who this might be right for
Hypertension, Pulmonary
Bayer 106
Not applicableStudy completedNCT01977014
What this trial is testing

NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up

Who this might be right for
Pulmonary Hypertension Group 1 and 4 According to Nice Classification
NordicInfu Care AB 40
Early research (Phase 1)Study completedNCT03489005
What this trial is testing

Effect of BIA 5 1058 on Cardiac Repolarization

Who this might be right for
Cardiovascular DiseasePulmonary Arterial HypertensionHeart Failure
Bial - Portela C S.A. 49
Not applicableLooking for participantsNCT04808596
What this trial is testing

Pulmonary Hypertension Biorepository and Registry

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Hypertension Due to Left Heart Disease+6 more
University of Kansas Medical Center 300